# Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy

> **NCT06618547** · NA · NOT_YET_RECRUITING · sponsor: **Bausch & Lomb Incorporated** · enrollment: 140 (estimated)

## Conditions studied

- Myopia

## Interventions

- **DEVICE:** TENEO 317 Model 2 excimer laser

## Key facts

- **NCT ID:** NCT06618547
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06618547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06618547, "Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06618547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*